Antimicrobial Susceptibility Testing (AST) procurement requires an intelligence-led approach that balances diagnostic accuracy, cost efficiency, supplier reliability, and evolving regulatory landscapes. Demand for AST solutions continues to rise as healthcare providers combat antimicrobial resistance and seek rapid, precise diagnostic tools. This demand growth, coupled with rapid technological innovation and complex supply chains, creates significant challenges across sourcing, pricing, and supplier management decisions.
Procurement teams must evaluate multiple interrelated factors, including supplier performance, pricing models, negotiation strategies, instrument compatibility, and regulatory considerations. Choices such as automated versus manual systems, reagent supply agreements, and data integration capabilities directly influence cost structures and operational efficiency. A comprehensive category intelligence view enables teams to benchmark suppliers, anticipate market risks, optimize negotiations, and unlock cost-saving opportunities, ensuring sustainable and competitive AST sourcing strategies.